Liz Highleyman

The complaint alleges the company has profited from research spearheaded by the CDC.

A new study confirms that providing clean drug injection equipment slows the spread of HIV.

Acting Commissioner Ned Sharpless will return to lead the National Cancer Institute.

The first study of PrEP awareness and use among transgender men found that a majority are at risk for HIV.

However, serious kidney problems and bone fractures were rare among people taking either Descovy or Truvada for HIV prevention.

Sci-B-Vac may offer more protection for older people and those with a weaker immune system.

Users of the social media app had a higher rate of some sexually transmitted infections but a lower rate of HIV.

As long-acting injectables near approval, daily pill versions of the same drugs show long-term benefit.

Surveys reveal difficulties associated with daily pills and a desire for long-acting injectable therapy.

Nine grants will enable researchers to study CBD and other components of marijuana.

Expanded access study confirms the long-acting monoclonal antibody works well in people with extensive prior treatment.

The new indication is for prevention of sexually transmitted HIV, with the exception of transmission via receptive vaginal sex.

The July conference will highlight San Francisco’s successes as well as persistent challenges in Oakland.

Judge’s ruling may pave the way for opening the nation’s first supervised overdose prevention facility.

CDC analysis shows the need for interventions to increase PrEP awareness and promote racial/ethnic equity in PrEP access.